[Nutrient restriction in combinatory therapy of tumors]

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• Anticancer treatments aim to eliminate tumor cells via programmed cell death.
• Monotherapy with chemotherapy or radiation often shows limited effectiveness due to tumor heterogeneity, virulence, and resistance.
• Single-agent therapies can also lead to significant adverse side effects.

Purpose of the Study:

• To review the potential of nutrient restriction (NR) as an adjunct therapy in cancer treatment.
• To explore the molecular mechanisms through which NR influences cancer cell death pathways.
• To highlight the benefits of combining NR with conventional chemotherapeutic drugs.

Main Methods:

• Literature review of studies investigating nutrient restriction and cancer.
• Analysis of molecular pathways involved in autophagy and apoptosis.
• Examination of preclinical and clinical data on combination therapies.

Main Results:

• Nutrient restriction can modulate autophagy and apoptotic cell death in cancer cells.
• Combining NR with chemotherapy may enhance tumor cell elimination.
• This combination strategy shows potential for improved therapeutic outcomes and reduced toxicity.

Conclusions:

• Nutrient restriction presents a promising strategy to augment conventional anticancer therapies.
• Further research into the molecular underpinnings of NR in cancer is warranted.
• Combination therapy involving NR and chemotherapy could represent a more effective and tolerable treatment paradigm.